¿´Æ¬Èí¼þ

Saturday 30 November 2024
Salisbury Foundation Trust

FOI_7539

Internal Reference Number: FOI_7539

Date Request Received: 09/11/2023 00:00:00

Date Request Replied To: 24/11/2023 00:00:00

This response was sent via: By Email

Request Summary: Treatment for Myelofibrosis

Request Category: Companies

 
Question Number 1:
Please provide the total number of patients treated in the last 6 months for:

• Polycythaemia Vera (ICD10 code D45)

• Myelofibrosis (ICD10 code D47.4)

• Myelofibrosis (ICD10 code D47.4) patients aged 65 and older
 
Answer To Question 1:
Polycythaemia Vera (ICD10 code D45) 47 patients

Myelofibrosis (ICD10 code D47.4) 13 patients

Myelofibrosis (ICD10 code D47.4) patients aged 65 and older 9 patients
 
Question Number 2:
How many patients were treated in the past 6 months (for any disease) with:

• Ruxolitinib

• Fedratinib

• Interferon (any type)
 
Answer To Question 2:
Ruxolitinib 11 patients

Fedratinib <5 patients

Interferon (any type) 6 patients
 
Question Number 3:
Of the patients treated in the past 6 months with Ruxolitinib, how many patients had a diagnosis for:

• Polycythaemia Vera (ICD10 code D45)

• Myelofibrosis (ICD10 code D47.4)
 
Answer To Question 3:
Polycythaemia Vera (ICD10 code D45) - > 5 patients

Myelofibrosis (ICD10 code D47.4) 10 patients
 
Question Number 4:
How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years?

• Of these patients, how many were treated in the past 6 months with Hydroxycarbamide?

• Of these patients, how many were treated in the past 6 months with Interferon therapy?

• Of these patients, how many have received no active treatment in the past 6 months?
 
Answer To Question 4:
Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? < 5 patients

Of these patients, how many were treated in the past 6 months with Interferon therapy? < 5 patients

Of these patients, how many have received no active treatment in the past 6 months? 8 patients
 
Question Number 5:
How many Polycythaemia Vera (ICD10 code D45) patients has your trust diagnosed in the past 3 years?

• Of these patients, how many were treated in the past 6 months with Hydroxycarbamide?

• Of these patients, how many were treated in the past 6 months with Interferon therapy?
 
Answer To Question 5:
Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? < 5 patients

Of these patients, how many were treated in the past 6 months with Interferon therapy? < 5 patients
 
Question Number 6:
Does your trust participate in any clinical trials for the treatment of myelofibrosis? If so, can you please provide the name of each trial along with the number of patients taking part.
 
Answer To Question 6:
none
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¿´Æ¬Èí¼þ Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury ¿´Æ¬Èí¼þ Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury ¿´Æ¬Èí¼þ Foundation Trust
Trust Values